Compliance With Dyslipidemia Guidelines in Daily Practice: How Effective Is Cardiovascular Risk Prevention?

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Practice Guidelines

Background:

• Atherosclerosis-related cardiovascular disease (CVD) is a primary cause of premature mortality.
• Current guidelines from Europe (SCORE system) and the US (pooled cohort equations) assess atherosclerotic CVD risk.
• Dyslipidemia management is crucial for CVD prevention.

Purpose of the Study:

• To evaluate compliance with dyslipidemia guidelines in daily practice for patients with dyslipidemia or CVD risk factors.
• To compare the achievement of LDL-C targets based on European and American guidelines.
• To analyze factors influencing the achievement of LDL-C goals.

Main Methods:

• A study of 500 outpatients with dyslipidemia or CVD risk factors.
• Risk stratification using European and American Heart Association guidelines.
• Comparison of achieved LDL-C levels with guideline-recommended targets, considering statin dosage.

Main Results:

• Under European guidelines, 231 patients were very-high/high risk, with only 45.9% achieving the LDL-C target (<100 mg/dL).
• Moderate-risk patients (n=210) had 74.3% goal achievement (<115 mg/dL), and low-risk patients (n=59) had 93.2% goal achievement (<155 mg/dL).
• Lower LDL-C levels and absence of coronary artery disease were associated with achieving LDL-C goals (P < 0.001).

Conclusions:

• The majority of patients in daily practice fall into very-high/high-risk categories for CVD.
• Despite the frequent use of European dyslipidemia guidelines, goal achievement for LDL-C is suboptimal.
• Improved adherence to and implementation of guidelines are necessary for effective CVD risk reduction.